Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury

Journal of Clinical Investigation

Volumn 117, Issue 7, 2007, Pages 1805-1813

  Han, Renzhi ^a   Bansal, Dimple ^a,c   Miyake, Katsuya ^b   Muniz, Viviane P ^a   Weiss, Robert M ^a   McNeil, Paul L ^b   Campbell, Kevin P ^a  

^a UNIVERSITY OF IOWA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSFERLIN; DYSTROPHIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL DAMAGE; CELL MEMBRANE; CELL REGENERATION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CYTOSKELETON; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; GENE MUTATION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART PROTECTION; MOUSE; MUSCLE NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; STRESS;

ANIMALS; CARDIOMYOPATHIES; DYSTROPHIN; HEART VENTRICLES; MEMBRANE PROTEINS; MEMBRANES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL ISCHEMIA; PHYSICAL CONDITIONING, ANIMAL; WOUND HEALING;

EID: 34447118089     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30848     Document Type: Article

References (45)

1. Graham, R.M., and Owens, W.A. 1999. Pathogenesis of inherited forms of dilated cardiomyopathy. N. Engl. J. Med. 341:1759-1762.
2. Towbin, J.A., and Bowles, N.E. 2006. Dilated cardiomyopathy: a tale of cytoskeletal proteins and beyond. J. Cardiovasc. Electrophysiol. 17:919-926.
3. Muntoni, F., et al. 1993. Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N. Engl. J. Med. 329:921-925.
4. Franz, W.M., et al. 2000. Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy. Lancet. 355:1781-1785.
5. Piccolo, F., et al. 1995. Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity. Nat. Genet. 10:243-245.
6. Barresi, R., et al. 2000. Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations. J. Med. Genet. 37:102-107.
7. Ben Hamida, M., Ben Hamida, C., Zouari, M., Belal, S., and Hentati, F. 1996. Limb-girdle muscular dystrophy 2C: clinical aspects. Neuromuscul. Disord. 6:493-494.
8. Coral-Vazquez, R., et al. 1999. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell. 98:465-474.
9. Tsubata, S., et al. 2000. Mutations in the human δ- sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J. Clin. Invest. 106:655-662.
10. Cohn, R.D., and Campbell, K.P. 2000. Molecular basis of muscular dystrophies. Muscle Nerve. 23:1456-1471.
11. Durbeej, M., and Campbell, K.P. 2002. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr. Opin. Genet. Dev. 12:349-361.
12. Allen, D.G. 2001. Eccentric muscle damage: mechanisms of early reduction of force. Acta. Physiol. Scand. 171:311-319.
13. McNeil, P.L., and Khakee, R. 1992. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am. J. Pathol. 140:1097-1109.
14. Clarke, M.S., Caldwell, R.W., Chiao, H., Miyake, K., and McNeil, P.L. 1995. Contraction-induced cell wounding and release of fibroblast growth factor in heart. Circ. Res. 76:927-934.
15. Bansal, D., et al. 2003. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature. 423:168-172.
16. Lennon, N.J., et al. 2003. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J. Biol. Chem. 278:50466-50473.
17. Bashir, R., et al. 1998. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat. Genet. 20:37-42.
18. Liu, J., et al. 1998. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat. Genet. 20:31-36.
19. Illa, I., et al. 2001. Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann. Neurol. 49:130-134.
20. Bittner, R.E., et al. 1999. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat. Genet. 23:141-142.
21. Ho, M., et al. 2004. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum. Mol. Genet. 13:1999-2010.
22. Kuru, S., et al. 2004. A patient with limb girdle muscular dystrophy type 2B (LGMD2B) manifesting cardiomyopathy. Rinsho Shinkeigaku. 44:375-378.
23. Yilmazer, S., et al. 2006. Cardiac involvement in a group of patients with dysferlinopathy [abstract]. Neuromuscul. Disord. 16:S110.
24. Anderson, L.V., et al. 1999. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum. Mol. Genet. 8:855-861.
25. Salani, S., et al. 2004. Developmental and tissue-specific regulation of a novel dysferlin isoform. Muscle Nerve. 30:366-374.
26. Soongswang, J., et al. 2002. Cardiac troponin T: its role in the diagnosis of clinically suspected acute myocarditis and chronic dilated cardiomyopathy in children. Pediatr. Cardiol. 23:531-535.
27. Duclos, F. 1998. Progressive muscular dystrophy in [alpha]-sarcoglycan- deficient mice. J. Cell Biol. 142:1461-1471.
28. Ervasti, J.M., Ohlendieck, K., Kahl, S.D., Gaver, M.G., and Campbell, K.P. 1990. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature. 345:315-319.
29. Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M., and Sweeney, H.L. 1993. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. U. S. A. 90:3710-3714.
30. Clarke, M.S., Khakee, R., and McNeil, P.L. 1993. Loss of cytoplasmic basic fibroblast growth factor from physiologically wounded myofibers of normal and dystrophic muscle. J. Cell Sci. 106:121-133.
31. Hoffman, E.P., Brown, R.H., Jr., and Kunkel, L.M. 1987. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 51:919-928.
32. Sicinski, P., et al. 1989. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science. 244:1578-1580.
33. Cox, G.A., Phelps, S.F., Chapman, V.M., and Chamberlain, J.S. 1993. New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin. Nat. Genet. 4:87-93.
34. Fuster, V., Badimon, L., Badimon, J.J., and Chesebro, J.H. 1992. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N. Engl. J. Med. 326:242-250.
35. Davis, D.B., Doherty, K.R., Delmonte, A.J., and McNally, E.M. 2002. Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains. J. Biol. Chem. 277:22883-22888.
36. McNeil, A.K., Rescher, U., Gerke, V., and McNeil, P.L. 2006. Requirement for annexin A1 in plasma membrane repair. J. Biol. Chem. 281:35202-35207.
37. Chakrabarti, S., et al. 2003. Impaired membrane resealing and autoimmune myositis in synaptotagmin VII-deficient mice. J. Cell Biol. 162:543-549.
38. Takahashi, T., et al. 2006. A case of dysferlinopathy presenting choreic movements. Mov. Disord. 21:1513-1515.
39. Galvin, J.E., Palamand, D., Strider, J., Milone, M., and Pestronk, A. 2006. The muscle protein dysferlin accumulates in the Alzheimer brain. Acta. Neuropathol. 112:665-671.
40. Izzedine, H., et al. 2006. Loss of podocyte dysferlin expression is associated with minimal change nephropathy. Am. J. Kidney Dis. 48:143-150.
41. Davis, D.B., Delmonte, A.J., Ly, C.T., and McNally, E.M. 2000. Myoferlin, a candidate gene and potential modifier of muscular dystrophy. Hum. Mol. Genet. 9:217-226.
42. Amalfitano, A., and Chamberlain, J.S. 1996. The mdx-amplification- resistant mutation system assay, a simple and rapid polymerase chain reaction-based detection of the mdx allele. Muscle Nerve. 19:1549-1553.
43. Hill, J.A., et al. 2000. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation. 101:2863-2869.
44. Zhou, M., et al. 1998. Insulin-dependent protein trafficking in skeletal muscle cells. Am. J. Physiol. 275:E187-E196.
45. Cohn, R.D., et al. 2001. Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex. J. Clin. Invest. 107:R1-R7.